Newsletter Oct 2011
21 Feb 2015
WWARN Published Date
- We invite researchers to participate in four WWARN Study Groups and pool their experience and knowledge to answer some of the outstanding questions about antimalarial resistance.
· - · WWARN scientists are calling for immediate action by researchers, funders and policy makers to focus on eliminating the threat of artemisinin resistance. Read more in the recent New England Journal of Medicine article.
- · In partnership with Global Health Trials, WWARN is launching new e-learning training courses on how to conduct high quality clinical trials.
- · WWARN's Quality Assurance/Quality Control programme is expanding and is now opening to all laboratories involved in pharmacology and in vitro work and a proficiency testing programme is being launched for molecular laboratories.